Loading...
MVC logo

Metrovacesa S.A.BME:MVC Rapporto sulle azioni

Cap. di mercato €1.6b
Prezzo delle azioni
€10.68
€10.81
1.2% sottovalutato sconto intrinseco
1Y-4.2%
7D-11.0%
Valore del portafoglio
Vista

Metrovacesa S.A.

Report azionario BME:MVC

Capitalizzazione di mercato: €1.6b

MVC Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Concorrenti di Metrovacesa S.A.

Storia dei prezzi e prestazioni

Riepilogo dei massimi, dei minimi e delle variazioni dei prezzi delle azioni per Metrovacesa
Prezzi storici delle azioni
Prezzo attuale dell'azione€10.68
Massimo di 52 settimane€13.50
Minimo di 52 settimane€8.82
Beta0.71
Variazione di 1 mese-10.40%
Variazione a 3 mesi-2.02%
Variazione di 1 anno-4.22%
Variazione a 3 anni52.57%
Variazione a 5 anni47.31%
Variazione dall'IPO-33.25%

Notizie e aggiornamenti recenti

Aggiornamento della narrazione May 02

MVC: Slightly Higher Required Return And Rich P/E Will Constrain Future Upside

Analysts have kept their average price target for Metrovacesa broadly steady around €10.81, citing only slight shifts in discount rate, profit margin assumptions and future P/E expectations rather than any major change in the investment case. Valuation Changes Fair Value: The €10.81 fair value estimate is unchanged, indicating a stable central valuation point in the model.
Aggiornamento della narrazione Apr 17

MVC: Higher Required Return And Rich P/E Will Pressure Future Returns

Analysts have kept their price target for Metrovacesa broadly unchanged at around €10.81 per share. The latest revisions reflect only very small model tweaks to the discount rate, revenue growth, profit margin and future P/E assumptions, rather than any shift in their core view.
Aggiornamento della narrazione Apr 03

MVC: Stable Assumptions And Discount Rate Tweaks Will Guide Future Returns

Analysts keep their Metrovacesa price target steady at €10.81, indicating largely unchanged assumptions on fair value, growth, margins, and future P/E, with only minor adjustments to discount rates and long-term expectations. Valuation Changes Fair Value: €10.81 per share is unchanged, suggesting the core view of what the stock is worth on a fundamental basis remains the same.

Recent updates

Aggiornamento della narrazione May 02

MVC: Slightly Higher Required Return And Rich P/E Will Constrain Future Upside

Analysts have kept their average price target for Metrovacesa broadly steady around €10.81, citing only slight shifts in discount rate, profit margin assumptions and future P/E expectations rather than any major change in the investment case. Valuation Changes Fair Value: The €10.81 fair value estimate is unchanged, indicating a stable central valuation point in the model.
Aggiornamento della narrazione Apr 17

MVC: Higher Required Return And Rich P/E Will Pressure Future Returns

Analysts have kept their price target for Metrovacesa broadly unchanged at around €10.81 per share. The latest revisions reflect only very small model tweaks to the discount rate, revenue growth, profit margin and future P/E assumptions, rather than any shift in their core view.
Aggiornamento della narrazione Apr 03

MVC: Stable Assumptions And Discount Rate Tweaks Will Guide Future Returns

Analysts keep their Metrovacesa price target steady at €10.81, indicating largely unchanged assumptions on fair value, growth, margins, and future P/E, with only minor adjustments to discount rates and long-term expectations. Valuation Changes Fair Value: €10.81 per share is unchanged, suggesting the core view of what the stock is worth on a fundamental basis remains the same.
Aggiornamento della narrazione Mar 20

MVC: Dividend Outlook And Revised Assumptions Will Shape Future Return Balance

Analysts now set their fair value estimate for Metrovacesa at €10.81 per share, up from €10.63. This reflects updated assumptions around the discount rate, revenue growth, profit margin and future P/E.
Aggiornamento della narrazione Mar 06

MVC: Lower Growth Assumptions And Elevated P/E Will Sustain Bearish View

Analysts have modestly lowered their price target on Metrovacesa to €9.30, citing updated assumptions for revenue growth, profit margins and the future P/E multiple, while keeping their fair value estimate unchanged at €9.30. Valuation Changes Fair Value: The fair value estimate is unchanged at €9.30 per share, indicating no revision to the overall valuation outcome.
Aggiornamento della narrazione Feb 20

MVC: Dividend Outlook And Updated Assumptions Will Shape Future Return Balance

Analysts have slightly trimmed their fair value estimate for Metrovacesa from €10.83 to €10.63, citing updated assumptions around discount rates, expected revenue growth, margins and future P/E levels. Valuation Changes Fair Value: Trimmed slightly from €10.83 to €10.63 per share.
Aggiornamento della narrazione Feb 06

MVC: Lower Discount Rate And High P/E Will Sustain Bearish View

Analysts have slightly raised their price target on Metrovacesa, citing updated assumptions for the discount rate, revenue growth, profit margins and future P/E, which together indicate a modestly higher fair value per share in euro terms. Valuation Changes Fair Value: unchanged at €9.30 per share.
Aggiornamento della narrazione Jan 23

MVC: Dividend Reserve Plans And P/E Revisions Will Guide Cautious Outlook

Analysts have maintained their Metrovacesa fair value target at €9.30, citing a combination of updated assumptions that include slightly lower discount rates, higher revenue growth expectations, softer profit margins and a higher future P/E multiple in their latest models. What's in the News Metrovacesa has scheduled a Special and Extraordinary Shareholders Meeting for November 25, 2025, at 13:00 Central European Standard Time in Madrid, Spain (Key Developments).
Aggiornamento della narrazione Jan 08

MVC: Dividend Proposal At Extraordinary Meeting Will Support Bullish Thesis

Analysts have revised their price target on Metrovacesa from €11.80 to €13.10, citing updated assumptions around discount rates, revenue growth, profit margins, and the future P/E multiple. What's in the News Metrovacesa has scheduled a Special and Extraordinary Shareholders Meeting for November 25, 2025, at 13:00 Central European Standard Time in Madrid, Spain (calle principe de vergara 187, plaza de rodrigo uria, madrid) (Key Developments) The meeting agenda includes a proposal to discuss the distribution of dividends from freely distributable reserves, which may be relevant if you are focusing on potential cash returns to shareholders (Key Developments) The notice also refers to discussion of other matters at the meeting, indicating that additional shareholder topics could be addressed beyond dividends (Key Developments) Valuation Changes Fair Value Estimate was revised from €11.80 to €13.10, indicating a higher assessed value per share.
Aggiornamento della narrazione Dec 24

MVC: Dividend Reserve Plans Will Shape A Cautious Medium-Term Outlook

Analysts have raised their price target on Metrovacesa from €6.50 to €9.30, citing higher expected revenue growth, improved profit margins, and a modestly richer future P/E multiple, despite a slightly higher discount rate. What's in the News Metrovacesa has called a special shareholders meeting for November 25, 2025, at 13:00 CET in Madrid to address key corporate matters.
Articolo di analisi Dec 20

Metrovacesa S.A. (BME:MVC) Shares Could Be 23% Below Their Intrinsic Value Estimate

Key Insights Metrovacesa's estimated fair value is €11.52 based on 2 Stage Free Cash Flow to Equity Current share price...
Aggiornamento della narrazione Dec 10

MVC: Dividend Decision And Revised Outlook Will Shape Balanced Return Prospects

Analysts have raised their price target on Metrovacesa from €9.81 to €10.83, citing a higher long term fair value despite moderating assumptions for revenue growth, profit margins and future earnings multiples. What's in the News Metrovacesa has scheduled a special and extraordinary shareholders meeting for November 25, 2025, at 13:00 Central European Standard Time in Madrid, Spain (Key Developments) The main agenda item for the upcoming meeting is the potential distribution of dividends from freely distributable reserves, which could affect shareholder returns policy (Key Developments) Shareholders will also address other unspecified matters at the meeting, leaving scope for additional corporate or capital structure decisions (Key Developments) Valuation Changes Fair Value: raised slightly from €9.81 to €10.83 per share, reflecting a modest uplift in long term valuation.
Articolo di analisi Oct 02

Should You Think About Buying Metrovacesa S.A. (BME:MVC) Now?

Metrovacesa S.A. ( BME:MVC ), is not the largest company out there, but it had a relatively subdued couple of weeks in...
Articolo di analisi Jul 25

Calculating The Fair Value Of Metrovacesa S.A. (BME:MVC)

Key Insights Using the 2 Stage Free Cash Flow to Equity, Metrovacesa fair value estimate is €12.58 Metrovacesa's €10.15...
Articolo di analisi May 04

Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Articolo di analisi Apr 12

Are Investors Undervaluing Metrovacesa S.A. (BME:MVC) By 40%?

Key Insights The projected fair value for Metrovacesa is €16.96 based on 2 Stage Free Cash Flow to Equity Metrovacesa...
Articolo di analisi Feb 26

Metrovacesa's (BME:MVC) Performance Is Even Better Than Its Earnings Suggest

Even though Metrovacesa S.A.'s ( BME:MVC ) recent earnings release was robust, the market didn't seem to notice. We...
User avatar
Nuova narrazione Feb 19

Will Leverage Undersupplied Spanish Housing Market For Future Opportunities

High presales coverage allows focus on margin maximization, boosting future net margins amid an undersupplied market.
Articolo di analisi Feb 07

Is It Time To Consider Buying Metrovacesa S.A. (BME:MVC)?

While Metrovacesa S.A. ( BME:MVC ) might not have the largest market cap around , it maintained its current share price...
Articolo di analisi Dec 13

An Intrinsic Calculation For Metrovacesa S.A. (BME:MVC) Suggests It's 44% Undervalued

Key Insights Metrovacesa's estimated fair value is €16.39 based on 2 Stage Free Cash Flow to Equity Metrovacesa's €9.13...
Articolo di analisi Sep 12

Estimating The Fair Value Of Metrovacesa S.A. (BME:MVC)

Key Insights The projected fair value for Metrovacesa is €9.93 based on 2 Stage Free Cash Flow to Equity Metrovacesa's...
Articolo di analisi Aug 01

We Think Metrovacesa's (BME:MVC) Profit Is Only A Baseline For What They Can Achieve

The subdued stock price reaction suggests that Metrovacesa S.A.'s ( BME:MVC ) strong earnings didn't offer any...
Articolo di analisi Jul 17

Is Now An Opportune Moment To Examine Metrovacesa S.A. (BME:MVC)?

While Metrovacesa S.A. ( BME:MVC ) might not have the largest market cap around , it saw significant share price...
Articolo di analisi May 28

A Look At The Intrinsic Value Of Metrovacesa S.A. (BME:MVC)

Key Insights Using the 2 Stage Free Cash Flow to Equity, Metrovacesa fair value estimate is €9.31 Current share price...
Articolo di analisi May 01

We Think Metrovacesa (BME:MVC) Can Stay On Top Of Its Debt

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Articolo di analisi Mar 27

Is Now An Opportune Moment To Examine Metrovacesa S.A. (BME:MVC)?

While Metrovacesa S.A. ( BME:MVC ) might not have the largest market cap around , it received a lot of attention from a...
Articolo di analisi Feb 12

A Look At The Fair Value Of Metrovacesa S.A. (BME:MVC)

Key Insights The projected fair value for Metrovacesa is €9.08 based on 2 Stage Free Cash Flow to Equity Current share...
Articolo di analisi Nov 05

Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Articolo di analisi Jul 05

These 4 Measures Indicate That Metrovacesa (BME:MVC) Is Using Debt Extensively

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Articolo di analisi May 21

Is Now An Opportune Moment To Examine Metrovacesa S.A. (BME:MVC)?

While Metrovacesa S.A. ( BME:MVC ) might not be the most widely known stock at the moment, it saw significant share...
Articolo di analisi Apr 19

Estimating The Intrinsic Value Of Metrovacesa S.A. (BME:MVC)

Key Insights Using the 2 Stage Free Cash Flow to Equity, Metrovacesa fair value estimate is €7.36 Current share price...
Articolo di analisi Dec 02

Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Articolo di analisi Sep 23

Is It Too Late To Consider Buying Metrovacesa S.A. (BME:MVC)?

While Metrovacesa S.A. ( BME:MVC ) might not be the most widely known stock at the moment, it received a lot of...
Articolo di analisi May 19

Estimating The Intrinsic Value Of Metrovacesa S.A. (BME:MVC)

Does the May share price for Metrovacesa S.A. ( BME:MVC ) reflect what it's really worth? Today, we will estimate the...
Articolo di analisi Mar 05

Metrovacesa's (BME:MVC) Strong Earnings Are Of Good Quality

Metrovacesa S.A. ( BME:MVC ) just reported healthy earnings but the stock price didn't move much. We think that...
Articolo di analisi Feb 16

Would Metrovacesa (BME:MVC) Be Better Off With Less Debt?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
Articolo di analisi Oct 05

Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Articolo di analisi Jul 02

Is Metrovacesa S.A. (BME:MVC) Worth €6.7 Based On Its Intrinsic Value?

Today we will run through one way of estimating the intrinsic value of Metrovacesa S.A. ( BME:MVC ) by projecting its...
Articolo di analisi May 06

Is Metrovacesa (BME:MVC) Using Too Much Debt?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Articolo di analisi Apr 06

Is Metrovacesa S.A. (BME:MVC) A Strong Dividend Stock?

Is Metrovacesa S.A. ( BME:MVC ) a good dividend stock? How can we tell? Dividend paying companies with growing earnings...
Articolo di analisi Mar 15

Metrovacesa (BME:MVC) Share Prices Have Dropped 51% In The Last Three Years

Metrovacesa S.A. ( BME:MVC ) shareholders should be happy to see the share price up 12% in the last month. But that...
Articolo di analisi Feb 16

Loss-Making Metrovacesa S.A. (BME:MVC) Set To Breakeven

We feel now is a pretty good time to analyse Metrovacesa S.A.'s ( BME:MVC ) business as it appears the company may be...
Articolo di analisi Jan 26

When Should You Buy Metrovacesa S.A. (BME:MVC)?

Metrovacesa S.A. ( BME:MVC ), might not be a large cap stock, but it led the BME gainers with a relatively large price...
Articolo di analisi Jan 05

A Look At The Fair Value Of Metrovacesa S.A. (BME:MVC)

In this article we are going to estimate the intrinsic value of Metrovacesa S.A. ( BME:MVC ) by taking the expected...
Articolo di analisi Dec 14

If You Had Bought Metrovacesa's (BME:MVC) Shares A Year Ago You Would Be Down 24%

Metrovacesa S.A. ( BME:MVC ) shareholders should be happy to see the share price up 11% in the last month. But that...

Rendimenti per gli azionisti

MVCES Real EstateES Mercato
7D-11.0%-3.3%2.1%
1Y-4.2%-1.3%22.7%

Ritorno vs Industria: MVC ha avuto una performance inferiore rispetto al Spanish Real Estate che ha registrato un rendimento -1.3 % nell'ultimo anno.

Rendimento vs Mercato: MVC ha avuto una performance inferiore al mercato Spanish che ha registrato un rendimento 22.7 % nell'ultimo anno.

Volatilità dei prezzi

Is MVC's price volatile compared to industry and market?
MVC volatility
MVC Average Weekly Movement5.7%
Real Estate Industry Average Movement3.8%
Market Average Movement3.9%
10% most volatile stocks in ES Market6.8%
10% least volatile stocks in ES Market0.9%

Prezzo delle azioni stabile: Negli ultimi 3 mesi il prezzo delle azioni di MVC è stato volatile rispetto al mercato Spanish.

Volatilità nel tempo: La volatilità settimanale ( 6% ) di MVC è rimasta stabile nell'ultimo anno, ma è comunque superiore al 75% delle azioni Spanish.

Informazioni sull'azienda

FondatoI dipendentiAMMINISTRATORE DELEGATOSito web
1918214Jorge de Leza Eguigurenwww.metrovacesa.com

Metrovacesa S.A. opera come società di sviluppo immobiliare in Spagna. L'azienda sviluppa e vende immobili residenziali e commerciali, oltre a vendere terreni. Metrovacesa S.A. è stata fondata nel 1918 e ha sede a Madrid, in Spagna.

Metrovacesa S.A. Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Metrovacesa con la sua capitalizzazione di mercato?
MVC statistiche fondamentali
Capitalizzazione di mercato€1.62b
Utili (TTM)€56.86m
Ricavi(TTM)€708.37m
28.5x
Rapporto P/E
2.3x
Rapporto P/S

Utili e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
MVC Conto economico (TTM)
Ricavi€708.37m
Costo del fatturato€528.83m
Profitto lordo€179.54m
Altre spese€122.68m
Utili€56.86m

Ultimi utili riportati

Dec 31, 2025

Prossima data di guadagno

Jul 22, 2026

Utile per azione (EPS)0.38
Margine lordo25.35%
Margine di profitto netto8.03%
Rapporto debito/patrimonio netto30.7%

Come si è comportato MVC nel lungo periodo?

Vedi performance storica e confronto

Dividendi

14.8%
Rendimento attuale del dividendo
n/a
Rapporto di remunerazione
Quando è necessario acquistare MVC per ricevere un dividendo imminente?
Metrovacesa date dei dividendi
Data di stacco del dividendoMay 20 2026
Data di pagamento dei dividendiMay 22 2026
Giorni fino al dividendo Ex2 days
Giorni prima della data di pagamento dei dividendi0 days

Analisi aziendale e situazione dei dati finanziari

DatiUltimo aggiornamento (ora UTC)
Analisi dell'azienda2026/05/20 12:14
Prezzo dell'azione a fine giornata2026/05/20 00:00
Utili2025/12/31
Utili annuali2025/12/31

Fonti dei dati

I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.

PacchettoDatiTempisticaEsempio Fonte USA *
Dati finanziari della società10 anni
  • Conto economico
  • Rendiconto finanziario
  • Bilancio
Stime di consenso degli analisti+3 anni
  • Previsioni finanziarie
  • Obiettivi di prezzo degli analisti
Prezzi di mercato30 anni
  • Prezzi delle azioni
  • Dividendi, scissioni e azioni
Proprietà10 anni
  • Top azionisti
  • Insider trading
Gestione10 anni
  • Team di leadership
  • Consiglio di amministrazione
Sviluppi principali10 anni
  • Annunci aziendali

* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.

Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.

Modello di analisi e Snowflake

I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.

Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.

Metriche di settore e industriali

Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.

Fonti analitiche

Metrovacesa S.A. è coperta da 22 analisti. 2 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.

AnalistaIstituzione
Ignacio RomeroBanco de Sabadell. S.A.
null nullBanco de Sabadell. S.A.
Mariano Miguel HidalgoBanco Santander